SWOG clinical trial number
SWOG-8926
Evaluation of Low Dose Continuous Infusion 5-Fluorouracil in Patients with Advanced and Recurrent Renal Cell Carcinoma
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Evaluation of Low Dose Continuous Infusion 5-Fluorouracil in Patients with Advanced and Recurrent Renal Cell Carcinoma
Activated
10/01/1989
Closed
02/15/1991
Publication Information Expand/Collapse
1994
Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma: A Southwest Oncology Group study.
1991
Efficacy of low dose continuous infusion 5-fluorouracil (LDCI-5FU) in recurrent/metastatic (r/m) renal cell carcinoma (RCC). A Southwest Oncology Group study.